Ranibizumab 0.5mg and 2.0mg to Treat Diabetic Macular Edema in Patients With Poor Response to Bevacizumab (REEF)

This study has been completed.
Sponsor:
Collaborator:
Genentech
Information provided by (Responsible Party):
California Retina Consultants
ClinicalTrials.gov Identifier:
NCT01292798
First received: February 7, 2011
Last updated: December 10, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2013
  Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)